Skip to main content
Clinical Trials/IRCT20170513033941N35
IRCT20170513033941N35
Completed
Phase 3

Clinical trial of the effect of selenium supplementation compared with the placebo on gene expression related to insulin and lipid in women with gestational diabetes mellitus

Iran University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with gestational diabetes mellitus.
  • Individuals aged 18 to 40 years.

Exclusion Criteria

  • Thyroid disorders
  • Pre\-eclampsia
  • Kidney or liver diseases
  • Requiring insulin therapy during intervention
  • Taking selenium supplements or other antioxidants 3 months before the intervention

Outcomes

Primary Outcomes

Not specified

Similar Trials